Today's Veterinary Practice

JUL-AUG 2011

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: http://todaysveterinarypractice.epubxp.com/i/38074

Contents of this Issue

Navigation

Page 30 of 83

ADVANCES IN STEM CELL THERAPY | 29. Brzoska M, Geiger H, Gauer S, Baer P. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 2005; 330:142-150. 30. Trottier V, Marceau-Fortier G, Germain L, et al. IFATS collection: Using human adipose- derived stem/stromal cells for the production of new skin substitutes. Stem Cells 2008; 26:2713-2723. 31. Zuk P. Retrospective: The adipose-derived stem cell: Looking back and looking ahead. Mol Biol Cell 2010; June 21:1782-1787. 32. Tobita M, Orbay H, Mizuno H. Adipose- derived stem cells: Current findings and future perspectives. Discovery Medicine 2011; 11(57):160-170. 33. Gimble J, Katz AJ, Bunnel B. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100:1249-1260. 34. Gimble J. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 2003; 3:705-713. 35. Marx R, Garg A. Dental and Craniofascial Applications of Platelet-Rich Plasma. Hanover, IL: Quintessence Publishing Co, Inc, 2005. 36. Mishra A, Woodall J, Viera A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009; 28(1):113-125. 37. Foster T, Puskas B, Mandelbaum B, et al. Platelet-rich plasma: From basic science to clinical applications. Amer J Sports Med 2009; 37(11):2259-2272. 38. Haynesworth SE, Kadiyala S, Liang LN, et al. Mitogenic stimulation of human mesenchymal stem cells by platelet release suggest a mechanism for enhancement of bone repair by platelet concentrates. Proc Ortho Res Soc, 2002. 39. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: The state of play. Br J Sports Med 2008; 42:314-320. 40. Marx R, Kevy S, Jacobson M. Platelet rich plasma (PRP): A primer. Practical Pain Management 2008; 8(2). 41. El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 2007; 78(4):661-669. 42. Little D, Guilak F, Ruch D. Ligament-derived matrix stimulates a ligamentous phenotype in human adipose-derived stem cells. Tissue Engineering: Part A 2009; 16(7):2307-2319. 43. Che X, Zou X, Yin G, Ouyang H. Tendon tissue engineering with mesenchymal stem cells and biografts: An option for large tendon defects? Front Biosci (School Ed) 2009; 1(1):23-32. 44. Uysal AC, Mizuno H. Tendon regeneration and repair with adipose derived stem cells. Curr Stem Cell Res Ther 2010; 5(2):161-167. 45. Uysal AC, Mizuno H. Differentiation of adipose-derived stem cells for tendon repair. Methods Mol Biol 2011; 702:443-451. 46. Uysal AC, Mizuno H. Tendon regeneration and repair with adipose derived stem cells. Curr Stem Cell Res Ther 2010; 5(2):161-167. 47. Jung M, Kaszap B, Redohl A, et al. Enhanced early tissue regeneration after matrix-assisted autologous mesenchymal stem cell transplantation in full thickness chondral defects in a minipig model. Cell Transplantation 2009; 18(8):923-932. 48. Lee K, Hui J, Song I, et al. Injectable mesenchymal stem cell therapy for large cartilage defects—a porcine model. Stem Cells 2007; 25:2965-2971. 49. Dragoo JL, Samimi B, Zhu M, et al. Tissue- engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003; 85:740-747. 50. Hsu WK, Wang JC, Liu NQ, et al. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am 2008; 90:1043- 1052. 51. Bacou F, el Andalousi RB, Daussin PA, et al. Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle. Cell Transplant 2004; 13:103-111. 52. Rodriguez LV, Alfonso Z, Zhang R, et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006; 108:12167-12172. 53. Goudenege S, Pisani DF, Wdziekonski B, et al. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther 2009; 17:1064-1072. 54. Santiago LY, Clavijo-Alvarez J, Brayfield C, et al. Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant 2009; 18(2):145-158. 55. Di Summa PG, Kingham PJ, Raffoul W, et al. Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg 2010; 63(9):1544- 1552. 56. Nakada A, Fukuda S, Ichihara S, et al. Regeneration of central nervous tissue using a collagen scaffold and adipose-derived stromal cells. Cells Tissues Organs 2009; 190:326-335. 57. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004; 22:560-567. 58. Dudas JR, Marra KG, Cooper GM, et al. The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects. Ann Plast Surg 2006; 56:543-548. 59. Yoon E, Dhar S, Chun D, et al. In vivo osteogenic potential of human adipose- derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007; 13:619-627. 60. Rosenbaum A, Grande D, Dines J. The use of mesenchymal stem cells in tissue engineering: A global assessment. Organogenesis 2008; 4(1):23-37. 61. Cousin B, Andre M, Arnaud E, et al. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun 2003; 21:1016-1022. 62. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129:118-129. 63. Kim WS, Park BS, Sung JH, et al. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007; 48(1):15-24. 64. Ebrahimian TG, Pouzoulet F, Squiban C, et al. Cell therapy based on adipose tissue- derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009; 29(4):503-510. 65. Trottier V, Marceau-Fortier G, Germain L, et al. IFATS collection: Using human adipose- derived stem/stromal cells for the production of new skin substitutes. Stem Cell 2008; 26:2713-2723. 66. Liang L, Mat T, Chen W, et al. Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res 2009; 39:822- 832. 67. Deng W, Han Q, Lia L, et al. Mesenchymal stem cells regenerate skin tissue. Tissue Engineering 2005; 11:110-119. 68. Long JL, Zuk P, Berke GS, Chhetri DK. Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering. Laryngoscope 2009:125-131. 69. Park BS, Jang KA, Sung JH, et al. Adipose- derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg 2008; 34:1323-1326. 70. Okura H, Matsuyama A, Lee CM, et al. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng Part C Methods 2010; 16(3):417-425. 71. Gonzalez-Rey E, Gonzalez MA, Varela N, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010; 69:241-248. 72. Lin G, Wang G, Liu G, et al. Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev 2009; 18:1399- 1406. 73. Lee ST, Chu K, Jung KH, et al. Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 2009; 66:671-681. 74. Riordan NH, Ichim TE, Min WP, et al. Non- expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009; 7:29. 75. Lin G, Wang G, Banie L, et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010; 12:88-95. 76. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration. Ten years of research and a literature review. J Nippon Med Sch 2009; 76(2):56-66. 77. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: An underappreciated source of stem cells for biotechnology. Trends Biotechol 2006; 24:150-154. 78. Strem B, Hicok K, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005; 54:132-139. 79. Prockop D, Phinney D, Bunnell B. Mesenchymal Stem Cells, Methods and Protocols. Clifton, NJ: Humana Press, 2008. 80. Alexander B. Autologous fat grafts as mesenchymal stormal stemcell source for use in prolotherapy: A simple technique to acquire lipoaspirants. J Prolother, August 2011. 81. Metallo C, Mohr J, Detzel C, et al. Engineering the stem cell microenvironment. Biotechnol Prog 2007; 23:18-23. Suggested Reading Alderman D. The new age of prolotherapy. Practical Pain Management, May 2010. July/August 2011 Today’s Veterinary Practice 29

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Practice - JUL-AUG 2011